Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 2, 2012, Pages 196-202

  Tanino, Yoshinori ^a,b   Chang, Mary Y ^b   Wang, Xintao ^a   Gill, Sean E ^b   Skerrett, Shawn ^b   McGuire, John K ^b   Sato, Suguru ^a   Nikaido, Takefumi ^a   Kojima, Tetsuhito ^c   Munakata, Mitsuru ^a   Mongovin, Steve ^d   Parks, William C ^b   Martin, Thomas R ^b,d   Wight, Thomas N ^e   Frevert, Charles W ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NAGOYA UNIVERSITY   (Japan)

^d VA Puget Sound Medical Center   (United States)

^e BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Innate immunity; Macrophages; Neutrophils; Proteoglycan; Syndecan

Indexed keywords

ALPHA CHEMOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 8; LOW MOLECULAR WEIGHT HEPARIN; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PROTEOHEPARAN SULFATE; SYNDECAN 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; EPITHELIAL CELLS; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN, LOW-MOLECULAR-WEIGHT; IMMUNITY, INNATE; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LUNG; LUNG INJURY; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NEUTROPHILS; PNEUMONIA; PNEUMONIA, BACTERIAL; RNA, MESSENGER; SYNDECAN-4; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MUS; NEGIBACTERIA;

EID: 84864554763     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0294OC     Document Type: Article

References (48)

1. Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med 2008;358:716-727.
2. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-384.
3. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-820.
4. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379-L399.
5. Jeyaseelan S, Chu HW, Young SK, Freeman MW, Worthen GS. Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infect Immun 2005;73:1754-1763. (Pubitemid 40470764)
6. Poltorak A, Smirnova I, Xiaolong H, Liu M, Huffel C, Birdwell D, Alejos E, Silva M, Du X, Thompson P, et al. Genetic and physical mapping of the Lps locus: identification of the Toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 1998;240:340-355. (Pubitemid 28524834)
7. Skerrett SJ, Wilson CB, Liggitt HD, Hajjar AM. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 2007;292:L312-L322. (Pubitemid 46103456)
8. Cai S, Batra S, Shen L, Wakamatsu N, Jeyaseelan S. Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J Immunol 2009;183:6629-6638.
9. Frevert CW, Huang S, Danaee H, Paulauskis JD, Kobzik L. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol 1995;154:335-344.
10. Gupta S, Feng L, Yoshimura T, Redick J, Fu SM, Rose CE Jr. Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung. Am J Respir Cell Mol Biol 1996;15:656-663. (Pubitemid 126440605)
11. Balamayooran G, Batra S, Fessler MB, Happel KI, Jeyaseelan S. Mechanisms of neutrophil accumulation in the lungs against bacteria. Am J Respir Cell Mol Biol 2010;43:5-16.
12. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997;155:1187-1205. (Pubitemid 27172758)
13. Zemans RL, Colgan SP, Downey GP. Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 2009;40:519-535.
14. Segel GB, Halterman MW, Lichtman MA. The paradox of the neutrophil's role in tissue injury: a review. J Leukoc Biol 2010;89:359-372.
15. Esko JD, Lindahl U. Molecular diversity of heparan sulfate. J Clin Invest 2001;108:169-173. (Pubitemid 32656238)
16. Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol 2006;6:633-643. (Pubitemid 44298213)
17. Gill S, Wight TN, Frevert CW. Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat Rec (Hoboken) 2010;293:968-981.
18. Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans finetune mammalian physiology. Nature 2007;446:1030-1037. (Pubitemid 46676065)
19. Frevert CW, Kinsella MG, Vathanaprida C, Goodman RB, Baskin DG, Proudfoot A,Wells TN,Wight TN,Martin TR. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am J Respir Cell Mol Biol 2003;28:464-472. (Pubitemid 36399368)
20. Tanino Y, Coombe DR, Gill SE, Kett WC, Kajikawa O, Proudfoot AE, Wells TN, Parks WC, Wight TN, Martin TR, et al. Kinetics of chemokine- glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs. J Immunol 2010;184:2677-2685.
21. Ellyard JI, Simson L, Bezos A, Johnston K, Freeman C, Parish CR. Eotaxin selectively binds heparin: an interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J Biol Chem 2007;282:15238-15247. (Pubitemid 47093355)
22. Reeves EP, Williamson M, Byrne B, Bergin DA, Smith SG, Greally P, O'Kennedy R, O'Neill SJ, McElvaney NG. IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis. J Immunol 2010;184:1642-1652.
23. Reeves EP, Williamson M, O'Neill SJ, Greally P, McElvaney NG. Nebulised hypertonic saline decreases interleukin-8 in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 2011;183:1517-1523.
24. Hayashida K, Parks WC, Park PW. Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 2009;114:3033-3043.
25. Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002;111:635-646. (Pubitemid 35441246)
26. Blackwood RA, Cantor JO, Moret J, Mandl I, Turino GM. Glycosaminoglycan synthesis in endotoxin-induced lung injury. Proc Soc Exp Biol Med 1983;174:343-349. (Pubitemid 14218242)
27. Karlinsky JB, Bucay PJ, Ciccolella DE, Crowley MP. Effects of intratracheal endotoxin administration on hamster lung glycosaminoglycans. Am J Physiol 1991;261:L148-L155.
28. Frevert CW, Sannes PL. Matrix proteoglycans as effector molecules for epithelial cell function. Eur Respir Rev 2006;14:137-144.
29. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 1996;154:1819-1828. (Pubitemid 26424956)
30. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycans in granulomatous lung diseases. Eur Respir J 1997;10:2731-2737. (Pubitemid 28052779)
31. Tanino Y, Makita H, Miyamoto K, Betsuyaku T, Ohtsuka Y, Nishihira J, Nishimura M. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002;283:L156-L162. (Pubitemid 34764552)
32. Smith LS, Gharib SA, Frevert CW, Martin TR. Effects of age on the synergistic interactions between lipopolysaccharide and mechanical ventilation in mice. Am J Respir Cell Mol Biol 2010;43:475-486.
33. Kassim SY, Gharib SA, Mecham BH, Birkland TP, Parks WC, McGuire JK. Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa. Infect Immun 2007;75:5640-5650. (Pubitemid 350207800)
34. Beutler B, Hoebe K, Georgel P, Tabeta K, Du X. Genetic analysis of innate immunity: identification and function of the TIR adapter proteins. Adv Exp Med Biol 2005;560:29-39.
35. Lin S-M, Frevert C, Kajikawa O, Wurfel MM, Ballman K, Mongovin S, Wong VA, Selk A, Martin TR. Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages. Am J Respir Cell Mol Biol 2004;31:162-170. (Pubitemid 39095446)
36. Kajikawa O, Frevert CW, Lin SM, Goodman RB, Mongovin SM, Wong V, Ballman K, Daubeuf B, Elson G, Martin TR. Gene expression of Toll-like receptor-2, Toll-like receptor-4, and MD2 is differentially regulated in rabbits with Escherichia coli pneumonia. Gene 2005;344:193-202. (Pubitemid 40126805)
37. Daubeuf B, Mathison J, Spiller S, Hugues S, Herren S, Ferlin W, Kosco-Vilbois M, Wagner H, Kirschning CJ, Ulevitch R, et al. TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J Immunol 2007;179:6107-6114.
38. Parker D, Prince A. Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol 2011;45:189-201.
39. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-964. (Pubitemid 41746764)
40. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008;181:3733-3739.
41. Novak R, Dabelic S, Dumic J. Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages. Biochim Biophys Acta (In press)
42. Axelsson J, Ferreira M, Adolfsson L, McCrea K, Ward R, Larm O. Cytokines in blood from septic patients interact with surface-immobilized heparin. ASAIO J 2010;56:48-51.
43. Kenig M, Gaberc-Porekar V, Fonda I, Menart V. Identification of the heparin-binding domain of TNF-alpha and its use for efficient TNF-alpha purification by heparin-Sepharose affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2008;867:119-125.
44. Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia: kinetics, kupffer cell expression, and glucocorticoid effects. Am J Pathol 1991;138:395-402.
45. Smith MF Jr, Novotny J, Carl VS, Comeau LD. Helicobacter pylori and Toll-like receptor agonists induce syndecan-4 expression in an NF-kappaB-dependent manner. Glycobiology 2006;16:221-229. (Pubitemid 43264688)
46. Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S, Schnyder B, Akira S, Quesniaux VFJ, Lagente V, et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 2007;117:3786-3799. (Pubitemid 350224089)
47. Jiang D, Liang J, Campanella GS, Guo R, Yu S, Xie T, Liu N, Jung Y, Homer R, Meltzer EB, et al. Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest 2010;120:2049-2057.
48. Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Iwase M, Yoshikai Y, Yanada M, Yamamoto K, Matsushita T, Nishimura M, et al. Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J Biol Chem 2001;276:47483-47488.